Sorafenib (Nexavar) - Oncology Nurse Advisor

Sorafenib (Nexavar)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews sorafenib (Nexavar), indicated for the treatment of unresectable hepatocellular carcinoma (HCC), advanced renal cell carcinoma (RCC), and locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) refractory to radioactive iodine treatment.

Table of Contents

Slide 4: Dosage and Administration
Slide 10: Cautions, Effects, and Interactions
Slide 17: What to Tell Your Patient
Slide 24: Reference

Next hm-slideshow in Slides